Latest Aggregates News

Harvey Norman Holdings reports a robust 9.1% increase in aggregated sales revenue across key international markets, supported by currency appreciation and selective store openings.

Infomedia Ltd’s acquisition by McQueen BidCo, backed by TPG Capital, has been legally approved, triggering trading suspension and scheduled shareholder payments.

Freehill Mining Limited has achieved its highest daily deliveries of industrial sand and gravel, fueling growth in Chile’s cement and construction sectors. The company is scaling operations with plant upgrades and expanding its customer base.

Worley Limited reported solid financial results for FY2025, highlighted by disciplined capital management including a $269 million share buy-back and a strong focus on sustainability. The company outlined strategic priorities and anticipates moderate growth in FY2026 with a new growth strategy to be revealed next year.

Serko Limited reports a robust 45% increase in total income for the first half of FY26, driven by its GetThere acquisition and strong momentum in Booking.com for Business, alongside a significant uplift in EBITDAFI.

Alcidion Group has expanded its contract with Leidos Australia, adding $12.3 million in value and increasing annual recurring revenue by $2.5 million through to 2028.

Monadelphous Group Limited has landed a suite of new contracts worth approximately $140 million, extending its foothold in the Pilbara and beyond with BHP and Rio Tinto.

Jayride Group Limited reported a $322K net cash outflow for the September quarter as it shifts from airport transfers to a SaaS mobility platform, raising $200K through convertible notes to support its transformation.

JAYRIDE Group Limited is advancing its transformation into a scalable Mobility-as-a-Service platform, securing new funding and expanding its SaaS footprint across the Asia-Pacific region.

NH3 Clean Energy has initiated the FEED phase for its WAH2 clean ammonia project, securing key partnerships and government support while raising $4 million to fuel development.

Neurizon Therapeutics has secured FDA clearance to resume clinical trials for its lead ALS drug candidate NUZ-001 and strengthened its balance sheet with a $5.2 million capital raise. The company is now poised to enter the pivotal HEALEY ALS Platform Trial, marking a significant step forward in its neurodegenerative disease program.

Venus Metals Corporation reports a significant update to its Sandstone gold resource, formalizes a joint venture with IGO at Bridgetown-Greenbushes, and reveals promising zinc and indium mineralisation at Youanmi.